GlassScriptPhysician profile
Tara Rhee Ring
NPI 1427441641
$5,334.34
in general payments reported to CMS, 2019-2025
38 companies · $1,871 in 2025
The $1,871 reported for 2025 was more than what 93% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $237 · 2023: $1,175 · 2024: $2,051 · 2025: $1,871.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,097.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,097.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $653.64 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $594.20 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $574.46 | 2023-2025 | Vraylar, Linzess |
| Pfizer INC. | $528.77 | 2023-2025 | |
| Amgen INC. | $413.92 | 2022-2025 | Repatha, Otezla, Repatha |
| Astrazeneca Pharmaceuticals LP | $357.31 | 2024-2025 | Airsupra, Farxiga, Breztri |
| Novartis Pharmaceuticals Corporation | $245.14 | 2023-2025 | |
| Abbott Laboratories | $206.19 | 2024 | Freestyle Libre 3 |
| Astellas Pharma US INC | $182.16 | 2023-2025 | Veozah, Myrbetriq |
| Edwards Lifesciences Corporation | $152.81 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $147.03 | 2023-2025 | Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $142.10 | 2022-2024 | |
| Exact Sciences Corporation | $118.70 | 2023-2025 | Cologuard Collection Kit |
| E.R. Squibb & Sons, L.L.C. | $110.67 | 2022-2025 | Eliquis, Camzyos |
| Phathom Pharmaceuticals, INC. | $106.41 | 2023-2025 | Voquezna |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $99.79 | 2023-2025 | Rexulti |
| Heartflow, INC. | $79.33 | 2025 | |
| Lundbeck LLC | $62.61 | 2023-2025 | Vyepti |
| Inspire Medical Systems, INC. | $62.46 | 2023-2024 | Inspire |
| Glaxosmithkline, LLC. | $54.54 | 2023-2024 | Shingrix, Arexvy, Bexsero |
| Janssen Pharmaceuticals, INC | $52.90 | 2022-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.54 | 2022-2025 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $43.68 | 2025 | Xifaxan |
| Medtronic, INC. | $42.07 | 2022-2025 | Intellis Adaptivestim, Minimed 780g |
| Merck Sharp & Dohme LLC | $32.32 | 2023 | Pneumovax 23, Vaxneuvance, Gardasil 9 |
| Dexcom, INC. | $26.76 | 2023 | Dexcom G7 Gss (161) |
| Idorsia Pharmaceuticals US INC | $23.89 | 2022 | |
| Ars Pharmaceuticals Operations, INC. | $20.24 | 2025 | Neffy |
| Nevro Corp. | $19.88 | 2023 | Senza |
| Philips North America LLC | $18.67 | 2024 | (Ck7) Extended Holter |
| Kyowa Kirin, INC. | $18.03 | 2024 | Crysvita |
| Horizon Therapeutics Plc | $15.65 | 2022 | |
| Dynavax Technologies Corporation | $14.96 | 2024 | Heplisav-B |
| Echosens North America, INC. | $14.12 | 2025 | Fibroscan |
| Azurity Pharmaceuticals, INC. | $13.85 | 2025 | Horizant |
| Xeris Pharmaceuticals, INC. | $13.73 | 2022 | |
| Sunovion Pharmaceuticals INC. | $12.66 | 2022 | |
| Daxor Corporation | $8.15 | 2023 | Bva-100 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Ring listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.